VRTX

7 Biotech Stocks to Add to Your Portfolio

By Portfolio Grader
The biotech business is working overtime to find the next breakthrough drugs and treatments for a population that gets older every day.

7 Biotech Stocks to Buy

By Louis Navellier, Editor, Growth Investor
With an aging U.S. population in need of healthcare, biotech stocks will grow with the demographic, providing an excellent chance to buy these 7 stocks.

Amazon Skewered After Hours — Tuesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
And Netflix, RadioShack got beat up during the day.

RIMM Completes a Week of Gloomy Outlooks — Friday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Research In Motion joined Intel, Best Buy and First Solar in forecasting leaner times ahead. Here's a look at RIM, as well as other big news from this week.

Dreary Day for Gold, Oil — Wednesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Gold breaks through its key $1,600 per ounce level

Merck CEO Pledges Drug Pipeline Will Yield Results in Both Short and Long Term

By Barry Cohen, Health Care Writer
Merck CEO Kenneth Frazier acknowledges company's lagging stock, touts potential of numerous drugs in late development stages.
Load More